Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells ; volume:10 ; number:1 ; day:18 ; month:11 ; year:2011 ; pages:1-15 ; date:12.2011
Molecular cancer ; 10, Heft 1 (18.11.2011), 1-15, 12.2011
- Creator
-
Sun, Ramon C.
Board, Philip G.
Blackburn, Anneke C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-10-142
- URN
-
urn:nbn:de:101:1-2021081220302082664736
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sun, Ramon C.
- Board, Philip G.
- Blackburn, Anneke C.
- SpringerLink (Online service)
Other Objects (12)
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
PML-RARA mutations confer varying arsenic trioxide resistance
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation